Forbion Growth Opportunities Fund I Cooperatief U.A.
CIK: 0001911047
Forbion Growth Opportunities Fund I Cooperatief U.A.'s purchase track record
How the stock did after each of Forbion Growth Opportunities Fund I Cooperatief U.A.'s open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
4
of 4 since December 27, 2023
Stock higher 6 months later
25%
3 months: 75%
Median 6-month return
-29.5%
3 months: +9.0%
Beat the S&P 500
0%
median -22.6% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/30/2024 | ENGN | $5.00M | -14.9% | -52.3% | -4.2% |
| 10/7/2024 | ENGN | $83K | +12.0% | -30.0% | -11.1% |
| 9/27/2024 | ENGN | $2.78M | +6.1% | -28.9% | -2.7% |
| 12/27/2023 | ENGN | $149K | +134.9% | +9.0% | +14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ENGN | ▲ Buy | Open Market | 561,797 | $5.0M | 10/30/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 800 | $5K | 10/8/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 11,844 | $78K | 10/7/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 5,997 | $39K | 10/4/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 5,769 | $37K | 10/3/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 10,153 | $65K | 10/2/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 35,279 | $227K | 10/1/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 341,332 | $2.2M | 9/30/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 38,396 | $228K | 9/27/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 3,243 | $21K | 9/27/2024 | View on chart |
| ENGN | ▲ Buy | Open Market | 400 | $3K | 12/29/2023 | View on chart |
| ENGN | ▲ Buy | Open Market | 9,620 | $87K | 12/29/2023 | View on chart |
| ENGN | ▲ Buy | Open Market | 5,050 | $39K | 12/28/2023 | View on chart |
| ENGN | ▲ Buy | Open Market | 2,750 | $20K | 12/27/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
enGene to Host KOL Webinar on Oct 15, 2026
enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.
enGene to Host KOL Webinar on Oct 15, 2026. enGene announced it will host a KOL webinar on Oct 15, 2026. The event will bring together key opinion leaders to discuss the company's therapeutic pipeline and clinical progress. The webinar could provide new insights for stakeholders and may influence market perception. The company remains in a lower part of its 52‑week range.